Results 301 to 310 of about 1,499,825 (316)

SGLT2 inhibition — a novel strategy for diabetes treatment

Nature Reviews Drug Discovery, 2010
Robert Henry, Henry Robert R
exaly  

Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes

Nature Reviews Drug Discovery, 2011
Frank Waldron-Lynch, Kevan Herold, Herold Kevan C   +2 more
exaly  

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine, 1993
D M Nathan, S Genuth, C Siebert
exaly  

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2008
Pavel Hamet, Paul P, Mark Cooper
exaly  

Type 2 diabetes as an inflammatory disease

Nature Reviews Immunology, 2011
Marc Donath, Steven Shoelson, Donath Marc Y   +2 more
exaly  

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine, 2015
Christoph Wanner, John Lachin, Bernard Zinman   +2 more
exaly  

Eczema and Type 1 diabetes

Diabetic Medicine, 2002
I F, Douek, N J, Leech, P J, Bingley, E A M, Gale   +3 more
openaire   +2 more sources

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

New England Journal of Medicine, 2001
Matti Uusitupa, Jaana Lindstrom, Johan Gunnar Eriksson   +2 more
exaly  

Effects of Intensive Glucose Lowering in Type 2 Diabetes

New England Journal of Medicine, 2008
Hertzel Gerstein, John Buse, Jeffrey L Probstfield   +2 more
exaly  

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2016
Jochen Seufert, Mark Warren, Ildikó Lingvay   +2 more
exaly